1.	Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: UCIRB #14735B, GV-001.010 (TNF-ELF), NCT00496236
2.	Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06U.195, NCT00358007
3.	Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-050, NCT00713219
4.	A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05C.255, NCT00329589
5.	Phase I Randomized Pilot Study of Adjuvant Mutant p53 Peptide-Pulsed Dendritic Cell Vaccine With or Without T-Helper Peptides in Patients With Squamous Cell Carcinoma of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: Over 18 Sponsor: NCI Protocol IDs: PCI-03-156, PCI-0507062, NCT00404339
6.	Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06C.549, NCT00437372
7.	Phase I Pilot Study of Photodynamic Therapy Comprising HPPH in Patients Undergoing Surgery For Primary or Recurrent Squamous Cell Cancer of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: RPCI-I-74606, NCT00470496
8.	Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Neck Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: H-29776, UMGCC 0804, NCT00704041
9.	Molecular Classification of Head and Neck Tumors Using cDNA Microarray Analysis to Detect Prognosis and Response to Therapy Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: NCI, Other Protocol IDs: 02-05-127E, NIH-R21-CA104402, NCT00200486
10.	Study of Insomnia in Patients Undergoing Chemoradiotherapy for Head and Neck Cancer Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: Over 21 Sponsor: NCI Protocol IDs: VU-VICC-SUPP-0742, VICC-SUPP-0742, NCT00616590
11.	A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy Phase: No phase specified Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 06-1210, NCT00608751
12.	A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07-03-080, NCT00627562
13.	STAT3 DECOY in Head and Neck Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCI 07-022, NCT00696176
14.	Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UFPTI 0604-SI01, NCT00797498